University of Vermont

UVM ScholarWorks
Graduate College Dissertations and Theses

Dissertations and Theses

2007

Evaluating the Moderating Role of Anxiety Sensitivity on Smoking
in Terms of Panic Psychopathology:
Alison Christine McLeish
University of Vermont

Follow this and additional works at: https://scholarworks.uvm.edu/graddis

Recommended Citation
McLeish, Alison Christine, "Evaluating the Moderating Role of Anxiety Sensitivity on Smoking in Terms of
Panic Psychopathology:" (2007). Graduate College Dissertations and Theses. 153.
https://scholarworks.uvm.edu/graddis/153

This Dissertation is brought to you for free and open access by the Dissertations and Theses at UVM
ScholarWorks. It has been accepted for inclusion in Graduate College Dissertations and Theses by an authorized
administrator of UVM ScholarWorks. For more information, please contact scholarworks@uvm.edu.

EVALUATING THE MODERATING ROLE OF ANXIETY SENSITIVITY ON
SMOKING IN TERMS OF PANIC PSYCHOPATHOLOGY:
A PROSPECTIVE TEST AMONG DAILY SMOKERS

A Dissertation Presented
by
Alison Christine McLeish
to
The Faculty of the Graduate College
of
The University of Vermont

In Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy
Specializing in Psychology
October, 2006

Abstract
The aim of the present investigation was to evaluate the moderating role of the physical
concerns domain of anxiety sensitivity (AS) in the relation between smoking rate and
panic vulnerability variables, both concurrently and prospectively, among a communitybased sample of 125 daily smokers (60 females; Mage = 26.02 years, SD = 10.98). As
hypothesized, there was a significant interaction between AS Physical Concerns and
smoking rate in relation to agoraphobic avoidance, such that at higher levels of AS
Physical Concerns and higher smoking rates, there was a risk for increased agoraphobic
avoidance (3.6% unique variance). Contrary to prediction, however, the interaction
between AS Physical Concerns and smoking rate did not significantly predict the
tendency to catastrophize about bodily sensations, body vigilance, or lifetime history of
panic attacks. In regard to the prospective analyses, there was a significant interaction
between AS Physical Concerns and smoking rate in relation to Time 2 anticipatory
anxiety, such that at higher levels of AS Physical Concerns and higher rates of smoking,
there was a significant risk for an increase in anticipatory anxiety over the three-month
follow-up period (5% unique variance). Contrary to prediction, the interaction between
AS Physical Concerns and smoking rate did not significantly predict the occurrence of
panic attacks during the three month follow-up period. The current findings suggest that
daily smokers smoking at higher rates with high AS Physical Concerns may be more
prone to engage in avoidance (Time 1 findings) and show increases in worry about
potentially threatening events in the future (Time 2 anticipatory anxiety findings). This
interaction appears to be relatively specific to only some aspects of panic-relevant
vulnerability factors. This pattern of findings may be used to conceptually guide the
refinement of etiological models of panic vulnerability that involve smoking behavior.

Acknowledgements
There are a number of people to whom I owe tremendous gratitude for help that was
given in the process of completing this project. I would like to thank my committee for
generously sharing their time and expertise. I would like to thank my parents, whose
constant love and support over the years have given me the strength, courage, and
determination to achieve my goals. I would also like to thank my “other” family- the
Anxiety and Health Research Lab. I am indebted to the AHRL team for not only their
practical support in completing this project but, more importantly, their friendship. I
would like to offer a special thanks to my research assistant, Meggan Bucossi, who was
instrumental in keeping this project running smoothly. I am also grateful to my friends,
old and new, who make life more enjoyable and help keep me sane. Lastly, I would like
to thank my mentor, Michael Zvolensky. His guidance and support have been invaluable
in my professional development and allowed me to accomplish more than I ever thought
possible.

ii

Table of Contents
Acknowledgements............................................................................................................. ii
List of Tables ...................................................................................................................... v
List of Figures .................................................................................................................... vi
Introduction......................................................................................................................... 1
Panic Disorder: Definition and Nature ........................................................................... 2
Theoretical Models of Panic Disorder Development...................................................... 4
Risk Factors: Conceptual Clarification........................................................................... 8
Smoking and Panic Disorder ........................................................................................ 10
Conceptual Model of Smoking and Panic .................................................................... 22
Present Study ................................................................................................................ 27
Method .............................................................................................................................. 30
Participants........................................................................................................................ 30
Measures ........................................................................................................................... 32
Time 1 Anxiety-related Measures................................................................................. 32
Time 1 Smoking-related Measures ............................................................................... 35
Time 2 Measures........................................................................................................... 36
Procedure .......................................................................................................................... 37
Screening....................................................................................................................... 37
Assessment.................................................................................................................... 37
Follow-Up ..................................................................................................................... 38
Results............................................................................................................................... 38
iii

Statistical Analyses ....................................................................................................... 38
Correlations for Theoretically-Relevant Variables....................................................... 39
Time 1 Regression Equations ....................................................................................... 41
Time 2 Regression Equations ....................................................................................... 43
Graphical Representation of the Statistically Significant Interactions ......................... 44
Discussion ......................................................................................................................... 45
Findings from Time 1 Assessment ............................................................................... 45
Findings from Time 2 Assessment ............................................................................... 49
Clinical Implications..................................................................................................... 52
Study Limitations and Future Directions...................................................................... 53
Conclusions................................................................................................................... 55
References......................................................................................................................... 57
Footnotes........................................................................................................................... 76

iv

List of Tables
Table 1: Key Terms in Risk Factor Research ................................................................... 78
Table 2: Overview of Procedure ....................................................................................... 79
Table 3: Descriptive Data & Intercorrelations among Predictor & Criterion Variables .. 80
Table 4: Contribution of the Interaction between AS Physical Concerns and Smoking
Frequency in Predicting Time 1 Panic-Relevant Variables............................... 81
Table 5: Contribution of the Interaction between AS Physical Concerns and Smoking
Frequency in Predicting Lifetime History of Panic Attacks.............................. 82
Table 6: Contribution of the Interaction between AS Physical Concerns and Smoking
Frequency in Predicting Time 2 Panic Attacks.................................................. 83
Table 7: Contribution of the Interaction between AS Physical Concerns and Smoking
Frequency in Predicting Time 2 Anticipatory Anxiety...................................... 84

v

List of Figures
Figure 1: Conceptual Model depicting Anxiety Sensitivity Moderating the Effects of
Smoking on Panic Vulnerability........................................................................ 85
Figure 2: Time 1 Agoraphobic Avoidance as a function of AS Physical Concerns and
number of cigarettes smoked per day among participants one-half of a standard
deviation above and/or below the mean for each predictor. .............................. 86
Figure 3: Time 2 Anticipatory Anxiety as a function of AS Physical Concerns and
number of cigarettes smoked per day among participants one-half of a standard
deviation above and/or below the mean for each predictor. .............................. 87

vi

Introduction
Anxiety disorders are among the most common classes of psychopathology. In the
National Comorbidity Survey and National Comorbidity Survey Replication (Kessler et
al., 1994; Kessler, Chiu, Demler, & Walters, 2005; Kessler, Berglund, Demler, Jin, &
Walters, 2005), anxiety disorders were more common than any other major group of
diagnoses (with the exception of substance use disorders) with a lifetime prevalence rate
of 25%. Aside from a high prevalence rate, anxiety disorders generally maintain a
chronic, fluctuating course (Pine, Cohen, Gurley, Brook, & Ma, 1998), resulting in
substantial impairment across the lifespan (Ferdinand & Verhulst, 1995). For instance,
one international study (Ormel et al., 1994) found more than half of patients with Panic
Disorder (PD) reported moderate to severe occupational dysfunction and physical
disability; the disability was similar to that of major depressive disorder and greater than
that for alcohol dependence. In addition to human suffering, anxiety disorders place a
large burden on the financial and social resources of society. According to one recent
estimate, the economic cost of anxiety disorders in the United States exceeds $42 billion
per year (Greenberg et al., 1999). Although there has been significant progress made in
developing efficacious treatments for anxiety disorders among children and adults (e.g.,
Barlow, Gorman, Shear, & Woods, 2000), only a very small percentage of those in need
of clinical services actually receive appropriate care [Institute of Medicine (IOM), 1989].
Interestingly, there have been very few attempts to develop and implement prevention
programs for anxiety psychopathology, which has been suggested to be due, in part, to
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the lack of understanding of what and how vulnerability processes impart risk for specific
disorders (see Feldner, Zvolensky, & Schmidt, 2004, for an expanded discussion).
Panic Disorder: Definition and Nature
Panic Disorder is a debilitating disorder that affects approximately 1.7% of the
adult U.S. population in any given year [National Institute of Mental Health (NIMH),
1999] and has a lifetime prevalence rate of 1.5%-3.5% worldwide [American Psychiatric
Association (APA), 2000; Kessler, et al., 1994]. Panic disorder is characterized by
recurrent, unexpected panic attacks and anxious apprehension about the possibility of
experiencing future panic episodes (Bouton, Mineka, & Barlow, 2001). The disorder
often is complicated by agoraphobia that can limit social involvement and/or personal
mobility (APA, 2000), other psychological disorders, and physical health problems
(Brown, Antony, & Barlow, 1995). Panic Disorder is regarded as a disorder of adulthood
with a median age of onset of 24 (Burke, Burke, Regier, & Rae, 1990). However, the
distribution of the age of onset for PD is bimodal with peaks at 15-24 and 45-54 years of
age (APA, 2000). Thus, both younger adults and middle-aged adults are at risk for
developing panic attacks and panic disorder, suggesting extending examinations of
emotional vulnerability for this problem to relatively wide age ranges. In the NIMH
Epidemiological Catchment Area study, Regier, Burke, and Burke (1990) found that PD
occurs twice as often in women than in men (2.1% vs. .9%). Similar results were found in
the National Comorbidity Survey, where the prevalence of PD was 2.5 times as likely in
women as in men (Kessler et al., 1994).
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Individuals with PD have one of the highest rates of service usage among the
anxiety disorders (Greenberg et al., 1999). In fact, patients with PD may see as many as
10 or more physicians and undergo numerous expensive and unnecessary procedures
before being diagnosed with the disorder (NIMH, 1995). PD is also associated with
financial problems; in one investigation, 60% of those with PD were unemployed and
37% of men and 42% of women with PD received some sort of financial assistance (e.g.,
disability, welfare, unemployment; Leon, Portera, & Weissman, 1995). Despite the
availability of efficacious treatments for PD, only 10-15% of individuals with the
disorder receive empirically supported clinical services (Goisman et al., 1994). Moreover,
there has been very little development in terms of preventive approaches for PD (APA,
2000; Kessler, et al., 1994).
It is noteworthy that a much larger percentage of the general population
experience panic attacks without necessarily developing PD (Norton, Cox, & Malan,
1992). Typically, individuals who experience these nonclinical panic attacks do not
experience these attacks as “spontaneous” or “uncued” as is generally the case in PD, but
rather in certain threat-based contexts such as stressful daily experiences or traumatic life
events (Bernstein et al., 2005). In fact, panic attacks are relatively common human
experience and readily occur across various clinical conditions (Barlow, Brown, &
Craske, 1994). From at least a heuristic level, some scholars have suggested panic attacks
can be conveniently conceptualized as falling along a continuum of severity with
nonclinical panickers scoring between clinical panickers and non-panickers on most
measures of psychopathology (Cox, Endler, & Swinson, 1991). It is important to note,
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however, that such a theoretical model (i.e., implicitly dimensional) has not been tested
empirically. Nonetheless, clinical and nonclinical panickers tend to use different coping
strategies to manage their panic (see Feldner, Zvolensky, & Leen-Feldner, 2004, for a
review) and this aspect has been discussed, albeit not extensively tested, as one critical
self-regulation difference that may help explain differential risk for developing panic
disorder (cf. nonclinical panic attacks). For instance, descriptive research suggests
nonclinical panickers employ positive coping strategies such as relaxation exercises,
while clinical panickers typically use avoidance and distraction as coping strategies (Cox,
Endler, Swinson, & Norton, 1992).
Theoretical Models of Panic Disorder Development
Several theories have been developed that attempt to explain PD. Although these
theories are not necessarily mutually exclusive, they each offer a different “point of
entry” in attempting to understand the etiology of PD. Biological theories point to an
overly sensitive suffocation alarm as an explanation for PD (Klein, 1993). In normal
individuals, when the suffocation alarm is activated, a “fight or flight” response occurs
and the individual experiences symptoms of breathlessness and the urge to flee. From an
evolutionary perspective, this system is purported to be adaptive as it might allow
humans to survive natural disasters and attacks by predators. However, individuals with a
hypersensitive suffocation alarm are believed to experience numerous “false alarms”
where these same symptoms are experienced in the absence of any threat. Feelings of
breathlessness are often followed by over-breathing and acute fear, which in these
hypersensitive individuals can lead to a panic attack. Given that these panic attacks are

4

purported to be elicited by slight fluctuations in levels of carbon dioxide, this theory may
account for patients’ reports that their panic attacks seem to come “out of the blue.”
Empirical evidence, however, has not supported this theory. For example, Gorman et al.
(2001) found that individuals with Premenstrual Dysphoric Disorder experienced panic
attacks in response to 5% and 7% CO2 inhalation at similar rates as individuals with PD.
Thus, while individuals with PD experience greater levels of anxiety in response to CO2
inhalation, it does not appear that this is necessarily due to specific physiological
abnormalities. Moreover, a variety of other studies have found that suffocation-based
fears (Eifert, Zvolensky, Sorrell, Hopko, & Lejuez, 1999; Taylor & Rachman, 1994) and
changes in CO2 are not associated with fear response to biological challenge (Schmidt,
Telch, & Jaimez, 1996). These sources of data do not support major theoretical
predictions derived from the suffocation-oriented theory of PD, and by extension, cast
doubt on the validity of such a perspective.
Alternatively, Barlow (1991, 2002) and Bouton et al. (2001) posit that panic
attacks are conditioning experiences that link anxiety and panic to both interoceptive and
exteroceptive cues. This type of perspective represents a learning theory of PD
development. Specifically, it is theorized that conditioned anxiety potentiates the next
panic attack in a downward negative spiral that culminates in PD. In this context, these
emotional events are not false alarms, but rather, learned alarms. The initial physical
symptoms of a panic attack are associated with the later full blown panic attack. Thus, the
individual becomes vigilant to slight fluctuations in physical functioning in order to
“prepare” (automatically) for the next attack. Because of the similarity in the
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unconditioned stimulus (US) and conditioned stimulus (CS), an index of
“belongingness,” fairly robust conditioning is posited to occur. By avoiding situations
that might elicit these interoceptive stimuli, the individual with PD prevents extinction of
this conditioning. Although this learning theory perspective of PD development is a
promising model for understanding PD, no empirical studies have been conducted to
explicitly test this theory. There is, however, a variety of indirect evidence that would be
consistent with this perspective, including that interoceptive-exteroceptive conditioning
(e.g., fear response pairing with visually based internal stimuli such as heart rate) is
quickly acquired and highly resistant to extinction (Forsyth & Eifert, 1996).
Clark’s (1986) cognitive theory of PD conceptualizes panic as stemming from
catastrophic misinterpretations of bodily sensations. Individuals with PD perceive normal
physical sensations in response to anxiety (e.g., heart palpitations) as a signal of
impending doom (e.g., having a heart attack). This misinterpretation causes a further
increase in anxiety, which then produces more physical sensations in a vicious cycle
ending in a panic attack. This holds true especially for ambiguous autonomic stimuli. In
fact, PD patients have been found to misinterpret ambiguous physical sensations more so
than those with other anxiety disorders and non-clinical controls (Clark et al., 1997).
Moreover, individuals who fear their own anxiety symptoms (i.e., high in anxiety
sensitivity) report catastrophic interpretation of ambiguous situations even prior to the
experience of panic attacks, suggesting the existence of a panic self-schema (Teachman,
2005). However, Rachman, Levitt, and Lopatka (1987) found that while panic episodes
were associated with more threat-relevant and fearful cognitions as well as increased
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physical symptoms, there were also a significant number of “non-cognitive” panic
episodes (e.g., nocturnal panic). The cognitive theory of PD is unable to explain these
non-cognitive panic episodes. Moreover, this cognitive theory of PD has been criticized
theoretically because it is potentially unfalsifiable, particularly as it was originally
conceived (McNally, 1999a).
Lastly, the Anxiety Sensitivity (AS) theory proposes that it is not the
misinterpretation of bodily sensations per se, but fear of actual physical sensations that is
the panicogenic process in PD development. AS is an individual difference variable that
indexes a “fear of fear” or a fear of anxiety symptoms themselves. Individuals high in AS
tend to believe that these physical sensations may cause serious physiological,
psychological, or social consequences. For example, if a person perceives bodily
sensations associated with autonomic arousal as a sign of imminent harm, this “high AS”
individual will likely experience elevated levels of anxiety and be at an increased risk for
panic. Moreover, this fear is posited to lead to avoidance of situations that would invoke
these sensations (e.g., avoiding exercise). The AS theory has received a great deal of
research attention in recent years with promising, independently replicated results. In
fact, several prospective studies have shown that AS can predict later panic attacks and
panic disorder (Schmidt, Lerew, & Jackson, 1997, 1999; Maller & Reiss, 1992) and that
AS has exhibited greater specificity to panic than temperamental variables such as
negative affectivity (Hayward, Killen, Kraemer, & Taylor, 2000). Extant research on AS
is more fully discussed later in the paper.
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Together, theoretical models of PD generally converge on the role of
interoceptive distress and fears of such bodily perturbation in the generation of panicrelated problems. Although naturally no one model can adequately account for all cases
of PD development at the present time, there are some promising findings, particularly in
regard to the AS theory. Nonetheless, it is noteworthy that none of the existing theories of
PD development explicitly focus on the role of behavioral factors in panic etiology, and
by extension, denote a specific role for behavioral factors in the disorder development.
As will be discussed, this lack of focus on behavioral factors is striking given PD is
highly associated with various types of addictive behaviors and that these behaviors
typically precede the onset of panic attacks and PD (Zvolensky, Schmidt, & Stewart,
2003). In some respects, this lack of scientific attention to drug-related problems in PD is
representative of a larger issue in anxiety disorder research: a failure to recognize and
systematically examine the role of substance use problems as specific vulnerability
factors for anxiety psychopathology (Zvolensky & Schmidt, 2004).
Risk Factors: Conceptual Clarification
Before proceeding further into a discussion of substance use problems in PD
etiology, it is important to first clarify what is meant by the term “risk.” Most of the
important theoretical work in defining risk concepts in contemporary clinical science has
originated from cutting-edge work in developmental psychopathology by Kazdin,
Kraemer, and their colleagues. They have defined a risk factor as a “characteristic,
experience, or event that, if present, is associated with an increase in the probability (risk)
of a particular outcome” (Kazdin, Kraemer, Kessler, Kupfer, & Offord, 1997, p.377).
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Like psychological disorders, risk factors are not typically best understood as static
entities. The association between risk factor and outcome depends on characteristics of
the population (age, sex), characteristics of the risk factor (duration, point in development
when exposed), other variables associated with the risk factor, and characteristics of the
outcome (Kazdin et al., 1997). In brief, risk factors are probabilistic in that they affect the
likelihood of a certain outcome but do not determine the outcome.
Risk factor research gives us an initial roadmap for identifying risk factors and a
way to increase specificity in our theoretical models of the etiology of particular
disorders. Kraemer et al. (1997) have conceptualized a hierarchy of influence of potential
risk factors and outcomes (see Table 1). The first step in this progression is to determine
whether or not there is an association between two characteristics. Next, temporal
relations must be established in order to show that the characteristic is a risk factor for a
particular outcome. Lastly, causality must be determined. A risk factor that is not causally
involved in a disorder is deemed a “marker” and can be either variable or fixed – terms
defined momentarily. If a risk factor is shown to influence the likelihood of the outcome
when manipulated, then it can be considered a causal risk factor. For example, a great
deal of recent research in the field of health psychology has attempted to elucidate the
causes of obesity. One factor that has been highlighted as a potential cause of obesity is
lack of exercise. In order to determine the nature of this association, studies would first
have to show that lack of exercise and obesity are related, thus establishing them as
correlates. The next step would be to determine whether or not lack of exercise preceded
obesity. Research would then need to demonstrate that lack of exercise always preceded
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obesity and that obesity never preceded lack of exercise. If this is shown to be the case,
then lack of exercise would be considered a risk factor for obesity. It would then be
necessary to determine what type of a risk factor lack of exercise may represent. If
research did not show that lack of exercise caused obesity, yet still preceded obesity, then
it would be considered a marker for obesity. Since lack of exercise is malleable, it would
be a variable marker. Had this marker been gender, a variable that is not malleable (i.e.,
changeable), it would be a fixed marker. If lack of exercise were found to be a variable
marker, future research would need to examine other correlates of lack of exercise to find
alternative pathways to obesity. If, on the other hand, changes in amount of exercise
changed one’s risk for obesity, then exercise would be considered a causal risk factor for
obesity. Although it is clear that exercise is not the only risk factor for obesity, it is one
lifestyle variable that can be manipulated to decrease the likelihood of obesity.
Collectively, this illustrative example highlights the importance and utility of explicating
risk factor effects in terms of better understanding health-related problems.
Smoking and Panic Disorder
As briefly mentioned in the above section, there has been a general lack of
attention paid to the role of addictive behaviors generally, and cigarette smoking
specifically, in anxiety disorders research. This lack of attention is striking and
potentially of great clinical concern, as there are likely bi-directional negative effects for
addictive behaviors to increase the risk of panic-related problems as well as the converse
(see e.g., Kushner, Abrams, & Borchardt, 2000; Kushner, Sher, & Beitman, 1990;
Stewart, Samoluk, & MacDonald, 1999; Zvolensky & Bernstein, 2005; Zvolensky &
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Schmidt, 2004; Zvolensky, Schmidt, & Stewart, 2003, for expanded discussions of this
issue). Before discussing bi-directional influences, however, it is perhaps useful to point
out one illustrative example of the degree of lack of knowledge of drug problems among
treatment specialists using one of the most common of the addictive drugs –
tobacco/cigarette smoking. One study recently examined knowledge and perceived
competence regarding smoking cessation among mental health professionals who
specialize in the treatment of anxiety disorders (Zvolensky, Baker, et al., 2005). Results
indicated that therapists assess smoking behavior in only about 30% of clients, perceive
themselves as “definitely unprepared” to deliver smoking cessation treatment, and only a
minority (18%) have received formal training in empirically-based smoking cessation
practices. When benchmarked against primary care physicians, anxiety specialists
illustrated deficits on “basic” cessation counseling practices (e.g., assess for smoking
behavior). Clearly, these data underscore that it is critically important to increase our
scientific knowledge of smoking-related processes and clinical attention to their role in
panic psychopathology.
Co-occurrence of smoking and panic-related problems. Smoking remains one of
the leading preventable causes of death and disability in the U.S., accounting for 440,000,
or 1 in 5, deaths each year [Centers for Disease Control and Prevention (CDC), 2004]. A
number of efforts have been made to understand the associations between smoking and
specific types of mental illness. The vast majority of this research has focused on
schizophrenia and depressive disorders (e.g., Ginsberg, Hall, Reus, & Muñoz, 1995;
Kinnunen, Doherty, Militello, & Garvey, 1996), whereas comparatively less attention has
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been devoted to the link between smoking and anxiety disorders. This lack of attention is
unfortunate, as anxiety disorders co-occur with smoking at rates that exceed those found
in the general non-psychiatric population and many other psychiatric conditions
(Amering et al., 1999; Beckham et al., 1997; Degenhardt, Hall, & Lynskey, 2001;
McCabe et al., 2004; Orlando, Ellickson, & Jinnett, 2001; Pohl, Yeragani, Balon, Lycaki,
& McBride, 1992). For instance, Lasser and colleagues (2000) recently found that among
4,000 respondents from the National Comorbidity Survey, current smoking rates for
respondents with an anxiety disorder in the past month or lifetime were significantly
greater than smoking rates among respondents with no mental illness. In this same study,
reported rates of smoking among those with anxiety disorders were highest among
individuals with panic-related problems (i.e., history of panic attacks and panic disorder)
and other anxiety disorders where panic attacks are common (i.e., posttraumatic stress
disorder and generalized anxiety disorder; Lasser et al., 2000). As a point of reference,
the percentages of smoking among people with nonclinical panic attacks and panic
disorder were greater than or equal to those found for major depressive disorder and
dysthymia (Lasser et al., 2000). These studies also indicate that the observed associations
between smoking and anxiety psychopathology are not due to sociodemographic
characteristics (e.g., gender), other psychiatric conditions (e.g., major depressive
disorder, alcohol dependence), or symptom overlap in diagnostic criteria for anxiety
disorders and nicotine dependence (Zvolensky, Schmidt, & Stewart, 2003). In fact, a
recent review found that, across all extant studies, the average rate of smoking among
those with panic-related problems is approximately 40% and panic-related problems are
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twice as prevalent among smokers compared to non-smokers (Zvolensky, Feldner, LeenFeldner, & McLeish, 2005). Other research indicates that a greater proportion of
individuals with PD report smoking at higher rates than individuals with social phobia
and obsessive-compulsive disorder (McCabe et al., 2004). These data suggest that
individuals with PD are likely to be heavier smokers than persons with other anxiety
disorders, and perhaps are more dependent on nicotine.1
Impact of Smoking on Panic-related Vulnerability. There are, of course, a
number of possible bi-directional influences between smoking and panic processes and
outcomes (e.g., predisposition models, pathoplastic models, spectrum models, scar
models; Clark, Watson, & Mineka, 1994). Recent research has begun to elucidate that
panic vulnerability factors such as AS and a history of panic attacks are associated with
(1) increases in the chance of early lapse and subsequent relapse to smoking (Brown,
Kahler, Zvolensky, Lejuez, & Ramsey, 2001; Zvolensky, Feldner, Eifert, & Brown,
2001; Zvolensky, Lejuez, Kahler, & Brown, 2004); (2) heightened negative affect during
quit attempts (Zvolensky, Baker et al., 2004; Zvolensky, Lejuez, et al., 2004; Zvolensky,
Schmidt, et al., 2005); and (3) smoking principally aimed to reduce negative affect states
(including withdrawal symptoms), but not for other motivational reasons (e.g., handling,
taste; Comeau, Stewart, & Loba, 2001; Novak, Burgess, Clark, Zvolensky, & Brown,
2003; Zvolensky, Feldner, et al., 2004; Zvolensky, Kotov, Antipova, & Schmidt, 2005).
These data highlight the potentially important role of panic vulnerability factors in
relapse-related problems and the maintenance of smoking more generally (i.e.,

13

predisposition models; Clark et al., 1994). Yet, smoking also may be associated with
increased risk of developing and/or exacerbating panic-related vulnerability.
Evidence has shown that smoking is associated with more severe panic problems
(e.g., pathoplastic models; Clark et al., 1994). A number of studies have been completed
in this domain. First, regular smokers with PD have been found to report more severe
anxiety symptoms (especially anticipatory anxiety) and social impairment than nonsmokers with PD (McCabe et al., 2004; Zvolensky, Schmidt, & McCreary, 2003). These
findings appear to be specific to PD as compared to anxiety disorders in general. A recent
study by Morissette, Brown, Kamholz, & Gulliver (in press) found that smokers with
anxiety disorders, as compared to their non-smoking counterparts, reported higher levels
of AS (overall, mental, and physical concerns), negative affect, anxiety, and agoraphobic
avoidance. However, this association appears to be due to the influence of panic disorder
with agoraphobia (PDA); when looking at smokers and nonsmokers with any anxiety
disorder other than PDA, no differences were found. Similar to previous findings, among
those with PDA, smokers reported greater interoceptive sensitivity, anxiety sensitivity
(overall, mental, and physical concerns), and life interference than nonsmokers. Second, a
biological challenge study indicated that smokers with PD reported greater levels of
anxiety and bodily distress than smokers without PD and than nonsmokers with PD
(matched on comorbidity criteria) at the post-challenge assessment and recovery period,
but no differences in autonomic responding during the challenge or in recovery
(Zvolensky, Leen-Feldner et al., 2004). Also, in terms of rate of recovery, the linear
decrease in anxiety, but not bodily distress, was significantly steeper for nonsmokers with
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PD than for smokers with PD. These data suggest smokers with PD are at risk for delayed
anxiety-related recovery from panic-relevant bodily perturbation, and moreover, due to
selection criteria, cannot be attributed to medical history or psychiatric comorbidity.
Finally, another investigation explored panic-relevant cognitive processes in a sample of
persons (n = 70) who met criteria for either (1) a positive nonclinical panic attack history
and regular smoking (smoking at least 10 cigarettes per day for > 12 months; PASM), (2)
a positive nonclinical panic attack history but no history of smoking (PA), or (3) regular
smoking history alone (smoking at least 10 cigarettes per day for > 12 months; SM)
(Zvolensky, Forsyth, Fuse, Feldner, & Leen-Feldner, 2002). PASM participants
demonstrated significantly greater body vigilance and anxiety sensitivity mental
incapacitation concerns compared to persons in either the PA or SM groups. The
observed effects, again, could not be attributed to self-reported physical health status or
history of medical problems. Although thus far restricted to a small number of crosssectional investigations, extant work indicates that there is indeed correlational evidence
that smoking is associated with increased risk of panic-related problems among persons
with a current history of PD and nonclinical panic attacks. These data help to establish an
association between these factors, but do not elucidate the temporal nature of that
association, and hence, cannot be used to infer etiological significance.
In addition to being associated with more severe panic problems, research
suggests smoking actually increases the risk of panic problems (predisposition models;
Clark et al., 1994). First, in regard to temporal nature, it is important to note that although
the onset of daily smoking typically occurs between the ages of 15 and 20 and rarely after
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age 25 (Breslau, Johnson, Hiripi, & Kessler, 2001), the median age of onset for PD is
typically 24 (Burke et al., 1990). This sequence would indicate that smoking initiation
generally precedes panic onset. As now will be discussed, outside of this general
evidence, there are a number of studies that have more specifically examined the
temporal relations between smoking onset and subsequent risk for panic vulnerability.
Using data from the Epidemiologic Study of Young Adults and the National
Comorbidity Survey Tobacco Supplement, Breslau and Klein (1999) found that daily
smoking increased the risk for the first occurrence of a panic attack or onset of PD, while
there was no significant risk for panic attacks or PD increasing the risk for smoking.
Individuals in the Epidemiological Study of Young Adults who were daily smokers and
had no history of major depression, specifically, were 3.96 times more likely to
experience a panic attacks than non-smokers (also without a history of major depression).
There was also a significant difference between the likelihood of experiencing a first
panic attack among those who continued to smoke and those who quit smoking (Hazard
Ratios = 4.71 and 0.21, respectively). Results were even more striking among persons
with PD. After controlling for a history of major depression, daily smokers were 13.13
times more likely to have PD than non-smokers. Again, the hazard ratio of smoking
initiation after the onset of PD was not significant. Results from the National
Comorbidity Study [reported in the same Breslau & Klein (1999) study], although
somewhat lower, paralleled the results from the Epidemiologic Study of Young Adults.
In a subsequent study by Breslau, Novak, and Kessler (2004) using the smoking
supplement to the National Comorbidity Survey, results indicated that current but not
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past smoking predicted later onset of PD and agoraphobia (Odds Ratios = 2.6 and 4.4,
respectively, without controlling for comorbid disorders) and that the risk of developing
these disorders decreased by half with each standard deviation unit of time since quitting.
Interestingly, neither nicotine dependence nor early onset smoking predicted the first
onset of psychiatric disorders. However, these studies were cross-sectional and employed
a unimethod (self-report) assessment protocol. Additionally, the age of onset for both
daily smoking and psychiatric disorders were assessed through retrospective recall and
subsequently subject to memory biases. Thus, while these results suggest that smoking
precedes the onset of panic, the reverse pathway cannot be definitively ruled out.
Addressing one of the limitations of the Breslau and Klein (1999) and Breslau et
al. (2004) studies, smoking has been established as a risk factor for PD through several
prospective studies. Johnson et al. (2000) conducted a longitudinal study examining the
relation between heavy cigarette smoking (> 20 cigarettes per day) and anxiety disorders
in adolescents and young adults. Results showed that anxiety disorders during
adolescence were not significantly related to smoking in young adulthood, however,
smoking in adolescence increased the risk for developing agoraphobia, GAD, and PD
during early adulthood. These effects were above the variance accounted for by
temperament, family history of psychopathology, drug/alcohol use and other
theoretically-relevant factors. Adolescents who were heavy smokers, specifically, were
15.58 times more likely to develop PD in early adulthood than non-smokers.
Interestingly, adolescents who smoked fewer than 20 cigarettes per day were not at
elevated risk for the development of later anxiety disorders, potentially suggesting
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heavier smoking levels impart greater panic-related risk. There are several interpretive
caveats to take into consideration with this study. First, assessments were unimethod
(interviews only) and therefore potentially subject to memory biases, recall distortion,
and capitalization of method variance. Second, because of low numbers of subjects with
certain diagnoses (< 10), sub-threshold levels of anxiety disorders were included in the
analyses making it difficult to fully discern the parameters of the association between
smoking and clinical levels of panic.
A second longitudinal study of smoking and panic was conducted in Germany
over a 4 year period with over 2,500 participants (aged 14-24 years at baseline; Isensee,
Wittchen, Stein, Höfler, & Lieb, 2003). Similar to Johnson et al. (2000), researchers
found a unidirectional association between prior smoking and later onset of panic
attacks/PD. Nicotine dependent smokers had an increased risk of later onset of panic
attacks. The risk for onset of PD was significant only among those who were nicotine
dependent smokers at baseline, although this association failed to reach statistical
significance after controlling for comorbid disorders. However, there was also a
significant association between panic and later onset of smoking dependence, making the
temporal relation between smoking and panic unclear. This study is noteworthy for two
reasons. First, it did not fully replicate the Johnson et al. (2000) study results in terms of
directionality. Second, it was the first to measure nicotine dependence, rather than
cigarettes consumed per day, as the primary smoking predictor variable. There are
important differences between cigarette smoking exposure (cigarettes consumed per day)
and nicotine dependence. In fact, these variables typically share only moderate
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associations with one another (Piper et al., 2004), potentially owing to relatively poor
conceptualizations of tobacco dependence. However, the Breslau et al. (2004) study
would indicate that smoking rate rather than nicotine dependence may be the primary
variable to examine. Future research will need to examine these two variables more
systematically in order to explicate the role of smoking in regard to panic-related
problems.
More recent research has attempted to identify other variables that influence the
smoking panic association. Zvolensky, Sachs-Ericsson, Feldner, and Schmidt (in press)
evaluated a moderational model of neuroticism on the association between smoking level
and panic attacks and panic disorder using data from the National Comorbidity Survey
(see below for a discussion of moderating variables). Participants (n = 924) included
current regular smokers, as defined by reporting smoking regularly during the past
month. Findings indicated that a generalized tendency to experience negative affect
(neuroticism) moderated the effects of maximum smoking frequency (i.e., number of
cigarettes smoked per day during the period when smoking the most) on lifetime history
of panic attacks and panic disorder even after controlling for drug dependence, alcohol
dependence, major depression and dysthymia, and gender. These effects were remarkably
specific to panic attacks and panic disorder, as no such moderational effects were
apparent for other anxiety disorders. It also is noteworthy that the main effects of
neuroticism and smoking frequency shared very little variance with one another (< 1%).
This finding is important, as it indicates that these two panic risk factors are tapping
different vulnerability processes.
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Finally, McLeish, Zvolensky, Bonn-Miller, and Bernstein (in press) examined the
moderating role of perceived health in the association between smoking and panic. In a
sample of daily smokers (n = 220), the interaction between health perceptions and
smoking rate incrementally predicted anxiety variables, but not depressive symptoms
even after controlling for alcohol consumption and gender. Furthermore, perceived health
shared no variance with smoking rate, indicating that these two variables are unique
factors. These results, in conjunction with Zvolensky, Sachs-Erricson, et. al. (in press),
suggest individual differences in certain affect variables that enhance emotional reactivity
or perhaps learning may be relevant to understanding which smokers experience or go on
to develop panic problems.
Together, a number of independently replicated investigations have found
smoking is associated with increased risk for developing panic problems. However, most
of the investigations are cross-sectional, focus on diagnostic status as a proxy for “panic
problems,” rather than assess for theoretically-relevant panic processes (e.g., types of
thinking patterns, behavioral styles), and do not confirm smoking status via biochemical
verification. Perhaps most importantly, all but two studies have focused on documenting
a main effect for smoking (see below for an additional example of a moderating effect).
This research focus made sense given the overall level of knowledge development in the
area. However, focusing solely on the main effect of smoking, as illustrated by the
Zvolensky, Sachs-Ericsson et al. (in press) and McLeish et al. (in press) results, may be
problematic and potentially misleading. To build upon this area of work, we need to
begin to identify moderators for the observed smoking effects.
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As defined by Baron and Kenny (1986) moderating variables are those that affect
the direction or strength of association between an independent and dependent variable.
In the present study, a moderator can be usefully conceptualized as a variable that
influences the association between smoking and panic vulnerability. In contrast,
mediators (variables that influence the relations between two correlated factors) serve to
qualify and explicate the nature of the observed co-occurrence. In general, it is useful to
conceptualize moderators as a pre-existing individual or environmental characteristic that
increases or decreases the risk of a certain outcome (e.g., promoting greater panic attacks
or greater risk of relapse). In contrast, mediators can be usefully conceptualized as factors
that are “triggered” by the presence of a variable (e.g., smoking) and thereafter serve to
account for the relation between that variable and an outcome (e.g., panic attacks).
In moderation, although both the independent and moderator variables may
significantly predict an outcome variable, it is the interaction between the two that is of
interest. Thus, moderators help to specify for whom or under what conditions a given risk
factor like smoking has negative (in this case, panic-related) effects. In short, they help
psychopathologists identify subpopulations with possibly (but not definitely) different
causal mechanisms or course of illness. As such, they provide critically important
information that can be used for highly pragmatic reasons, including guiding intervention
planning. For example, they might suggest that certain pockets or collections of
individuals might be the most apt to develop panic-related problems and therefore it may
make the most sense to focus clinical activities (e.g., implementation of prevention
programs) on this particular sub-group in the population.
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Considering the above mentioned challenges to previous work, we now turn to a
discussion of potentially moderating variables for smoking in regard to panic
vulnerability.
Conceptual Model of Smoking and Panic
An emerging pressing question from extant work is: what variables may moderate
the effects of smoking on panic-related vulnerability? Zvolensky, Schmidt, and Stewart
(2003) and Zvolensky and Bernstein (2005) have offered an integrative theoretical model
for better understanding smoking-related effects on panic psychopathology. This model
specifies a number of different theoretically-relevant pathways for smoking to exert
negative effects on panic outcomes [e.g., via its effects on physical health functioning,
direct pharmacological effects, perceived health status, promotion of life stress
(particularly health-related adverse events and potentially time pressures secondary to
“integrating” smoking into one’s occupational and personal life), maladaptive coping,
and withdrawal symptoms] and a number of individual difference and contextual factors
that can help clarify (or place explanatory parameters on) these pathway specific effects.
The focus of the present study is on clarifying individual difference characteristics
that might moderate the effects of smoking on theoretically-relevant panic-related
processes. Toward this end, there needs to be an attempt to conceptually integrate
important work on AS and smoking in one overarching model. As briefly discussed
above, AS is a dispositional, trait-like cognitive characteristic that is unique from the
temperamental variable of trait anxiety (McNally, 1999b) and is theorized to predispose
individuals to the development of panic problems (Reiss & Havercamp, 1996). For

22

example, if a person perceives bodily sensations that are associated with autonomic
arousal as a sign of imminent personal harm, this “high anxiety sensitive” individual is
theorized to experience elevated levels of anxiety and be at an increased risk for a panic
attack. At least three lines of research have strongly supported this line of theorizing.
First, prospective studies with adolescents and adults indicate AS predicts the future
occurrence of panic attacks and worry about the future occurrence of such attacks
(Schmidt et al., 1997; Weems, Hayward, Killen, & Taylor, 2002). These same
prospective studies and other cross-sectional investigations indicate AS is relatively
specific to PD and does not covary with other phenomena distinct from the syndrome
(e.g., depression; Schmidt, Lerew et al., 1999). Second, AS is a significant predictor of
responses to panic provocation procedures in the laboratory even after controlling for
negative affectivity (Zinbarg, Brown, Barlow, & Rapee, 2001); these effects are limited
to AS Physical Concerns, rather than Mental or Social Concerns. Thus, fear of bodily
sensations and interoceptive cues are particularly relevant to panic vulnerability. Finally,
AS is elevated among persons with a history of PD compared to those without the
disorder (Taylor, Koch, & McNally, 1992). Because AS also decreases with remission of
panic psychopathology through intervention (Telch et al., 1993), unlike many other panic
risk factors (e.g., family history of PD, personal history of panic attacks), it can easily be
targeted for therapeutic change in future prevention work.
AS may be critically important to PD vulnerability by serving to moderate the
effect of smoking on the development of panic-related processes (see Figure 1 for a
schematic of this process). Smoking promotes interoceptive sensations in a number of
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ways, including withdrawal symptoms, cardiopulmonary impairment, and respiratory
irritations, as well as medical diseases (CDC, 2004). In fact, recent research suggests one
reason for the link between smoking and panic is due to the effects of smoking on
respiratory function (Caldirola, Bellodi, Cammino, & Perna, 2004). Among persons with
high levels of AS (particularly Physical Concerns), such interoceptive sensations are
likely to be experienced as anxiety-provoking. Indeed, AS Physical Concerns has been
shown to be a significant predictor of fear responding to bodily sensations during
biological challenge (Brown, Smits, Powers, & Telch, 2003; Carter, Suchday, & Gore,
2001; Zinbarg et al., 2001; Zvolensky et al., 2002). Specifically, AS may increase the
likelihood that such interoceptive events will be interpreted as uncontrollable or
personally threatening, thereby intensifying anxious responding. The high AS Physical
Concerns individual experiencing bodily sensations related to smoking would therefore
be exposed to more frequent and intense aversive interoceptive learning trials. In this
manner, smoking-related cues concerning somatic arousal or other interoceptive
experiences are more likely to become phobic stimuli (Barlow, 2002). In contrast,
individuals low in AS Physical Concerns may be less susceptible to the panic-related
effects of smoking because they are less fearful of bodily sensations.
In this context, it is important to remember that cues that trigger panic attacks are
not always immediately obvious to individuals, thus generating the perception that panic
attacks are “out of the blue.” Additionally, interoceptive cues are typically perceived as
less predictable than exteroceptive cues (Craske, 1991; Lejuez, Eifert, Zvolensky, &
Richards, 2000). These latter points are important, because some of smoking-related
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interoceptive effects (e.g., withdrawal) may be “predictable” and “expected” for regular
smokers. However, it is unlikely smokers will always (i.e., on every single occasion) be
aware of these cues and experience them as “predictable.” Moreover, even expected
aversive bodily experiences may be potentially panic-relevant events for certain
individuals.
Although not the focus of the present study, it is important to note that this
“affective bind” might place these high-risk persons at risk for smoking as an affect
management tactic. In fact, numerous lines of evidence support the idea that people,
including regular smokers, use tobacco as a means of regulating their mood and coping
with stress, attributing their smoking to its alleged anxiolytic properties (Frith, 1971);
reliably reporting that they smoke more when stressed or anxious (Shiffman, 1993); and
holding the expectation that smoking helps reduce negative affect (Copeland, Brandon, &
Quinn, 1995). Although no single mechanism can presently explain the association
between smoking and negative affect, a key finding that has emerged from this literature
is that smoking effects on anxiety-related states are highly dependent on other factors
related to affective processing (Gilbert & Gilbert, 1998). Specifically, research suggests
that smoking-related effects on emotional processing are largely indirect and variability
in response to smoking is strongly affected by individual difference factors (Kassel,
Stroud, & Paronis, 2003).
There have only been two tests of the AS-smoking moderator hypothesis in regard
to panic vulnerability. In one study, the sample was drawn from the population of adult
residents of Moscow using a geographic sampling method, producing an
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epidemiologically-defined (i.e., representative) sample (Zvolensky, Kotov, Antipova, &
Schmidt, 2003). Results of this cross-sectional study indicated that AS moderated the
effects of smoking (n = 95 daily smokers from a larger sample of about 400 persons), as
indexed by cigarettes per day (m = 15 cigarettes per day), in terms of level of
agoraphobic avoidance; this significant interaction accounted for approximately 10% of
unique variance after controlling for their respective main effects and the theoreticallyrelevant factors of problem alcohol use and negative affectivity. No interaction, however,
was found for panic attacks, potentially due to the fact that assessment of this factor was
restricted to the past (most recent) week to enhance the validity of panic reports (but
probably truncating variability). It also is noteworthy that AS and cigarette smoking were
not correlated with one another, suggesting that they represent different risk factors for
panic problems. The second test of the AS-smoking moderator hypothesis was conducted
with a community sample of adolescents (n = 206; Leen-Feldner, et al., in press). Results
indicated that after controlling for gender, negative affect, and the main effects of AS and
smoking rate, AS moderated the effects of smoking status (yes/no) in terms of panic
attack symptoms (3% variance) and somatic complaints (1% variance), but not
depression. Specifically, those individuals who were both current smokers and high in AS
reported the highest rate of panic-related symptoms. As with the Zvolensky, Kotov, et al.
(2003) study, AS and smoking shared little variance with one another providing further
support that these two variables represent distinct risk factor for panic problems.
Overall, these findings suggest smokers are not a homogeneous group in regard to
their risk for panic problems and that individuals differences in AS (or other affect-
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enhancing factors) are a key factor in accounting for such differences. However, the
results are limited in a number of important ways. First, the studies were cross-sectional
in nature. Second, they relied on self-report and interview methodologies. Third, as with
earlier studies, smoking status was not confirmed with biochemical assessments. Fourth,
they focused on the general AS factor, leaving unclear whether or not the observed
effects were better accounted for by one or more of the specific sub-domains (i.e., AS
Physical Concerns, but not Mental or Social Concerns). Finally, there was a limited range
of theoretically-relevant dependent variables and none focused on panic-related
information processing.
Present Study
The overarching purpose of the proposed investigation was to replicate and
extend past work by testing the moderating role of AS in regard to smoking frequency
effects on panic vulnerability among a sample of adult regular smokers. Within this
context, there were two main conceptually related, albeit distinct, domains to investigate:
one dealing with a cross-sectional test (to broaden past work by identifying associations
with heretofore undocumented panic-related processes) and the other involving a
prospective test (to document changes in panic attacks and associations with anticipatory
anxiety across time). In both cases, the present investigation sought to test the interaction
between the physical concerns sub-domain of AS and cigarettes per day in regard to
panic-relevant processes implicated in the aforementioned biopsychosocial model of
panic disorder etiology (Zvolensky, Schmidt, & Stewart, 2003; Zvolensky & Bernstein,
2005). Cigarettes per day, rather than nicotine dependence, may be particularly relevant
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to panic vulnerability, as it is a more direct index of “exposure” or “experience” and not
addiction (i.e., tobacco dependence). That is, it may be a more direct assessment of
“smoke exposure” and thereby presumably be more likely than tobacco dependence to be
associated with increased risk of bodily sensations (e.g., via lung impairment). Likewise,
AS Physical Concerns is the most theoretically-relevant composite for panic vulnerability
and therefore the focus of the present study.
In regard to the cross-sectional test, it was expected that after controlling for
negative affectivity and weekly average alcohol consumption (frequency x quantity
composite), the interaction between the Physical Concerns subfactor of AS and cigarettes
per day would be uniquely and significantly predictive of: (1) the tendency to
catastrophize about bodily sensations (using Agoraphobic Cognitions Questionnaire), (2)
body vigilance (using Body Vigilance Questionnaire), (3) agoraphobic avoidance [using
interview-rated pre-morbid (i.e., prior to panic disorder development) agoraphobic
avoidance behavior via the Panic Disorder Severity Scale], and (4) lifetime history of
panic attacks (assessed via the SCID-NP [non patient version] panic attack module).
These hypotheses were premised on previous work documenting an interactive effect of
AS on smoking outcomes in terms of self-reported agoraphobic avoidance (Zvolensky,
Schmidt, & McCreary, 2003) and the previously discussed conceptual model which
suggests through learning experiences with smoking-related interoceptive cues (e.g.,
withdrawal symptoms, lung impairment) smokers with high, but not low, levels of fear of
bodily sensations will be more apt to focus attention on such events,
misinterpret/catastrophize them as personally dangerous, and cope with them via

28

avoidance-oriented affect regulation strategies (including but not limited to smoking)
because they are perceived as personally “harmful” or “personally threatening.” 2
In terms of the prospective test, it was expected that after controlling for Time 1
levels of panic attacks (or anticipatory anxiety in the second analysis), the interaction
between the Physical Concerns subfactor of AS and cigarettes per day would, within a 3month prospective assessment, be uniquely and significantly predictive of: (1) total
frequency of panic attacks (assessed via the SCID-NP [non patient version] panic attack
module) and (2) anticipatory anxiety (assessed via the Panic Disorder Severity Scale).
This model did not use the same covariates as the cross-sectional tests, as the total sample
size was smaller due to (a) studying only those persons with panic attacks and (b)
attrition. The second set of hypotheses were attempting to document theoreticallyrelevant associations between the AS Physical Concerns and cigarettes per day
interaction and future-based panic-relevant emotional vulnerability. Overall, it was
expected that the form of the significant interaction would indicate persons high in AS
Physical Concerns and average number of cigarettes consumed per day, compared to
persons scoring low on one or both of these measures, would be more likely to
experience a panic attack during the three-month follow-up period and exhibit higher
levels of Time 2 anticipatory anxiety. Although this prospective test naturally was not
focused on developmental processes per se due to the relatively limited window of time
allowed in the assessment, it did permit us to chart the degree of variability (with a
directional focus) in one key panic-relevant process. In this sense, it represents an
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important facet of study at this stage of research development in regard to panic-smoking
vulnerability processes.
Method
Participants
The sample consisted of 125 daily smokers (60 females; Mage = 26.02 years, SD =
10.98). Participants were recruited through the University of Vermont using
advertisements for daily smokers in the campus newspaper and flyers posted on bulletin
boards located in buildings and commons areas around campus. Participants also were
recruited through the general community using newspaper advertisements and flyers
posted in a local, well-traveled marketplace as well as in local restaurants and bars;
identical advertisements were used for both the university and community sectors. The
racial composition of the studied sample generally reflected that of the local population
(State of Vermont Department of Health, 2000): approximately 95% of the sample was
Caucasian, 4% African-American, and 1% other. Approximately 10% of the sample had
at least a 4-year college education, 74% had some college education, 10% had a high
school degree or the equivalent, and the remaining 6% did not have a high school
education.
Participants smoked on average 17.6 cigarettes per day (SD = 8.43), had smoked
cigarettes regularly for 7.61 (SD = 8.49) years, began cigarette smoking at a mean age of
13.48 (SD = 2.91) years, and considered themselves regular smokers by a mean age of
15.79 (SD = 2.8) years. When smoking tobacco the heaviest, participants averaged 24.43
(SD = 12.43) cigarettes per day. The average level of nicotine dependence, as indexed by
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the Fagerstrom Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker,
& Fagerstrom, 1991), was 3.37 (SD = 2.02); this reflects a low level of overall nicotine
dependence. Expired carbon monoxide (CO) levels also were evaluated to verify smoking
status. The average CO level for the current sample was 16.2 ppm (SD = 11.23); scores
above 8 ppm are considered indicative of regular smoking (please see Smoking Measures
section for details). 69.6% (n = 87) of the participants were regular alcohol users,
drinking 5 to 6 alcoholic beverages approximately 2 to 3 times per week.
Participants reported the following lifetime history of medical problems: 37.6%
had allergies, 16.8% had experienced some type of head injury, 9.6% had been diagnosed
with hypertension, 8% had been diagnosed with heart problems, 16% had been diagnosed
with asthma, 6.4% had some other form of respiratory disease, and 2.4% had epilepsy.
Participants were administered the Structured Clinical Interview for DSM-IV Axis I
Disorders- Non-Patient Edition (First, Spitzer, Gibbon, & Williams, 1995) and reported
the following history of current or past psychiatric problems: 28% had major depressive
disorder, 25.6% had experienced non-clinical panic attacks, 11.2% had post-traumatic
stress disorder, 4.8% had generalized anxiety disorder, 4.8% had social phobia, and 2.4%
had obsessive-compulsive disorder.
Participants were excluded from the study if they displayed limited mental
competency or the inability to give informed, written consent. Participants were not
excluded for medical or psychiatric illness other than panic disorder. Participants with
panic disorder were excluded from the study, as the aim of the study was to explore
vulnerability processes for panic disorder; therefore, if panic disorder was not
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exclusionary criterion, it would not be possible to ascertain if the AS Physical Concerns
by smoking rate effects were simply attributable to this condition rather than being a
potential risk-conferring process.
Measures
Time 1 Anxiety-related Measures
Structured Clinical Interview for DSM-IV Axis I Disorders- Non-Patient Edition
(SCID-NP). The SCID-NP (First et al., 1995) is a well-established diagnostic interview
for psychiatric problems, including panic attacks. It assesses Axis I disorders and
provides a sub-module for panic attacks (including limited symptom attacks). The
interview was administered in full at Time 1 in order to determine participants’ history of
psychiatric problems. Reliability ratings by an independent rater (MJZ) were completed
on a random selection of 20% of the protocols, with no cases of disagreement being
noted.
Anxiety Sensitivity Index (ASI). The ASI (Reiss, Peterson, Gursky, & McNally,
1986) is a 16-item measure that asks respondents to rate on a 5-point Likert scale (0 =
very little to 4 = very much) the degree to which they fear negative consequences
stemming from anxiety symptoms. Responses to each item are summed to provide a total
score from 0-64. Previous research indicates that the ASI is made up of one higher-order
factor (ASI Total Score) and three lower-order factors: Physical, Psychological, and
Social Concerns (Zinbarg, Barlow, & Brown, 1997; Stewart, Taylor, & Baker, 1997;
Rodriguez, Bruce, Pagano, Spencer, & Keller, 2004). The ASI shows adequate test-retest
reliability (r = .75 for two weeks), criterion validity (e.g., individuals with agoraphobia
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score higher than those with other anxiety disorders and those with no disorder), and is
distinct from trait anxiety (Reiss et al., 1986). The ASI also shows specificity in its
relation to anxiety but not to depression (Schmidt, Lerew, & Joiner, 1998). Recent
findings converge on the observation that the Physical Concerns dimension, specifically,
is most relevant to panic attack vulnerability (Zinbarg et al., 2001; Rodriguez et al.,
2004). Thus, the AS Physical Concerns dimension was employed as a predictor variable
at Time 1 in the present study.
Agoraphobic Cognitions Questionnaire (ACQ). The ACQ is a 14-item scale
measuring thoughts around the negative consequences of experiencing anxiety
(Chambless, Caputo, Bright, & Gallagher, 1984). Items are rated on a 5-point Likert scale
from (1) thought never occurs to (5) thought always occurs. The ACQ is comprised of 2
factors: social/behavioral concerns and physical concerns. The ACQ has been shown to
have high internal consistency (Cronbach alpha = .87), moderate test-retest reliability (r =
.67 for one month) and sensitivity to changes due to treatment (Chambless et al., 1984).
The ACQ can also discriminate clinical from non-clinical groups, especially individuals
with anxiety disorders (Chambless & Gracely, 1989). The ACQ total score was used to
index anxiety related cognitions and was administered at Time 1 (a criterion variable).
Body Vigilance Scale (BVS). The BVS was employed to assess attentional focus
on somatic symptoms (Schmidt, Lerew, & Trakowski, 1997). The BVS is a 4-item
instrument in which respondents indicate on an 11-point Likert-type scale (0 = none to 10
= extreme) the degree to which they agree with a particular statement regarding
attentional focus on body sensations and related processes. Specifically, three of the items
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measure attentional focus, perceived sensitivity to changes in body sensations, and the
average duration of time spent attending to body sensations. A fourth item involves
having participants rate their attention to 15 body sensations, as defined by the DSM-IV
physical symptoms for panic attacks. Responses to the fourth item are averaged to yield a
single score for that item. Summing the four items derives a total score for the BVS.
Research suggests that the BVS has adequate internal consistency (alpha =.75) and can be
used to assess changes in bodily attention during cognitive-behavioral treatment for panic
disorder (Schmidt, Lerew, & Trakowski, 1997). The BVS was administered at Time 1 in
the present study and served as a primary index of body vigilance.
Panic Disorder Severity Scale (PDSS). The PDSS is a semi-structured interview
rating scale for PD (Shear, et al., 1997) that includes ratings of panic frequency and
intensity, anticipatory anxiety, and avoidance of sensations and situations, and
impairment in work and social functioning. Each of these symptoms is rated on a 0
(None) to 4 (Extreme) scale. The PDSS has good psychometric properties (Shear et al.,
1997; Shear et al., 2001). In our lab, two clinicians making PDSS ratings in a dual
interview were found to have consistently high reliability (Zvolensky, Leen-Feldner et
al., 2004). In the present investigation, we computed two ratings: (1) anticipatory anxiety
using the anticipatory anxiety question (item 3) and (2) agoraphobic avoidance using a
composite of avoidance of situations and avoidance of bodily sensations (items 4 and 5).
These ratings were examined separately because past work had shown relations of AS by
smoking in regard to avoidance and other anxiety constructs (Zvolensky, Kotov et al.,
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2003). Thus, it was important to separate avoidance from other anxiety factors relevant to
panic vulnerability.
Positive Affect Negative Affect Schedule (PANAS). The PANAS is a mood
measure commonly used in psychopathology research (Watson, Clark, & Tellegen,
1988). It assesses two global dimensions of affect: negative and positive. Only the
negative affectivity scale (PANAS-NA) was used in this study. A large body of literature
supports validity of the PANAS (Watson, 2000). For example, the PANAS-NA possess
good internal consistency (Cronbach’s alpha = .84-.87) and reliability (r = .71) (Watson
et al., 1988). In the present investigation, the PANAS-NA subscale was employed as a
covariate.
Time 1 Smoking-related Measures
Smoking History Questionnaire (SHQ). Smoking history and pattern was assessed
with the SHQ, a measure that includes items pertaining to smoking rate, age of onset of
initiation, years of being a regular smoker, etc. The SHQ has successfully been used in
previous studies as a measure of smoking history (Brown, Lejuez, Kahler, & Strong,
2002; Zvolensky, Lejuez, et al., 2004). The SHQ was administered at Time 1 only and
the average cigarettes per day variable was used as a primary predictor variable.
Fagerstrom Test for Nicotine Dependence (FTND). The FTND is a six-item scale
designed to assess gradations in tobacco dependence (Heatherton et al.,1991). The FTND
is a revision of the Fagerstrom Tolerance Questionnaire (FTQ; Fagerstrom, 1978). The
FTND has shown good internal consistency, positive relations with key smoking
variables (e.g., saliva cotinine; Heatherton et al, 1991; Payne, Smith, McCracken,
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McSherry, & Antony, 1994), and high degrees of test-retest reliability (Pomerleau,
Carton, Lutzke, Flessland, & Pomerleau, 1994).
Expired Carbon Monoxide. Biochemical verification of smoking status was
completed by carbon monoxide (CO) analysis of breath samples assessed using a Bedfont
Micro III Smokerlyzer CO Monitor (Model EC50; Bedfont Scientific USA, Medford,
NJ). Research indicates that 8 ppm is an optimal cutoff score for reliably discriminating
smoking status (Jarvis, Tunstall-Pedoe, Feyerabend, Vesey, & Saloojee, 1987). Obtained
values above this cutoff were considered indicative of smoking at Time 1.
Alcohol Use Disorders Identification Test (AUDIT). The AUDIT is a 10-item
screening measure developed by the World Health Organization to identify individuals
with alcohol problems (Babor, de la Fuente, Saunders, & Grant, 1992). Most items are
rated on a 5-point Likert scale from (0) never to (4) daily or almost daily. Scores range
from 0-40 with a score of 8 indicating a likelihood of alcohol use problems. Major areas
of problematic drinking that are assessed include: alcohol consumption, drinking
behavior (dependence), adverse psychological reactions, and alcohol-related problems.
There is a large body of literature attesting to the validity of the AUDIT (Saunders,
Aasland, Babor, de la Fuente, & Grant, 1993). In the present investigation, we used the
frequency and quantity items of the AUDIT to index alcohol consumption at Time 1 and
employed this index as a covariate.
Time 2 Measures
The SCID-NP Panic Attack Module was administered at Time 2 in order to assess
panic attacks during the past three months (i.e., criterion variable). The Panic Disorder
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Severity Scale (PDSS) was re-administered at Time 2 to document change in anticipatory
anxiety ratings over the 3-month assessment. Only the SCID-NP panic module and PDSS
were re-administered, rather than all panic-relevant measures, as these were the only two
factors theorized to possibly show systematic change in the 3-month time period.
Procedure
Screening
An overview of the entire procedure can be seen in Table 2. Initial screening
procedures were completed via telephone. Interested individuals were given a brief
description of the study and asked about smoking status. Potentially eligible participants
then scheduled an assessment appointment at the Anxiety and Health Research
Laboratory (AHRL).
Assessment
Upon arrival to the assessment appointment, participants were administered the
SCID-NP to more thoroughly assess whether or not subjects met inclusion criteria and
document their psychiatric history as well as the Panic Disorder Severity Scale. After
completing the interview, smoking status was biochemically verified via CO analysis.
Subjects then completed the following self-report measures: Anxiety Sensitivity Index,
Agoraphobic Cognitions Questionnaire, Body Vigilance Scale, Positive and Negative
Affect Scale, Smoking History Questionnaire, and the Alcohol Use Disorders
Identification Test (about 90-minutes in total time for session 1). Subjects were then
given instructions regarding procedures for the follow-up period and given $20
compensation.
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Follow-Up
During the 3-month prospective phase, reminder calls were placed at 1.5 months
to keep in touch with participants; specifically, at 1.5 months, we contacted participants
via telephone to ensure that their contact information had not changed and reminded them
about the upcoming follow-up assessment. If their phone number had changed or was
disconnected, we then attempted to contact them via letter. After three months, subjects
were contacted to schedule their follow-up assessment. Subjects returned to the
laboratory and were administered the following measures: SCID-NP panic attack module
and the Panic Disorder Severity Scale. Subjects were then debriefed and given $30
compensation for their efforts.
Results
Statistical Analyses
The main and interactive effects of smoking rate and AS Physical Concerns for
the primary dependent variables were evaluated using a hierarchical multiple regression
(or logistic regression for binary dependent variables) procedure (Cohen & Cohen, 1983).
For the first set of analyses, separate models were constructed for predicting (1) the
tendency to catastrophize about bodily sensations (ACQ), (2) body vigilance (BVS), (3)
agoraphobic avoidance (composite avoidance score from the PDSS), and (4) a lifetime
history of panic attacks (SCID; this analysis used a logistic regression). Negative
affectivity and weekly alcohol consumption were entered as covariates at step one in the
model. At the second step the main effects for smoking rate and AS Physical Concerns
were simultaneously entered into the model in order to estimate the amount of variance
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accounted for by these variables individually. At the third step, the interaction term
(mean centered) between smoking rate and AS Physical Concerns was entered into the
model (Baron & Kenny, 1986).
Hierarchical multiple regression also was employed for the prospective test to
determine if the interaction between AS Physical Concerns and cigarettes per day at Time
1 accounted for unique variance in predicting the presence of panic attacks during the
follow-up period (SCID; logistic regression was employed for this analysis due to the
binary nature of the dependent variable) and change in anticipatory anxiety at Time 2.
Separate models were, again, constructed for each of the dependent variables: panic
attacks and anticipatory anxiety at Time 2. History of panic attacks was entered as a
covariate at step 1 for the panic attack analysis, and level of anticipatory anxiety at Time
1 was entered as a covariate for the anticipatory anxiety analysis; this approach allowed
for an initial test of “change” for each factor, which is consistent with the a priori
hypotheses. AS Physical Concerns and cigarettes smoked per day at Time 1 were entered
together at step 2 to evaluate the main effects of these variables. Lastly, the mean
centered interaction term (AS Physical Concerns x cigarettes per day at time 1) was
entered at step 3 to test whether AS Physical Concerns at Time 1 moderated the relation
between smoking history at Time 1 and panic attacks and anticipatory anxiety at Time 2.
Correlations for Theoretically-Relevant Variables
The first step to understand the nature of the data was to compute a series of
conceptually-relevant zero-order correlations for each of the different assessment time
points (Time 1 and 2). Here, zero-order correlations were first computed to assess the
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association between the primary predictor variables (smoking rate and AS Physical
Concerns) and the covariates at Time 1. Then, correlations were computed to assess the
association between the primary predictor variables (smoking rate and AS Physical
Concerns) and the primary dependent variables at Time 1. Finally, zero-order correlations
were then computed for primary predictor variables (smoking rate and AS Physical
Concerns) and the Time 2 dependent measures.
Associations among predictor variables and covariates at Time 1. Negative
affectivity was significantly correlated with AS Physical Concerns (r = .67, p < .01), but
not alcohol consumption (r = .03, p = .70) or smoking rate (r = .14, p = .11). Alcohol
consumption was significantly correlated with smoking rate (r = -.30, p < .01), but not
with AS Physical Concerns (r = .02, p = .84). The correlation between smoking rate and
AS Physical Concerns was minimal (r = -.04, p = .70).
Associations among predictor and criterion variables at Time 1. Smoking rate
was significantly associated with lifetime history of panic attacks (r = .19, p < .05), but
not the tendency to catastrophize about bodily sensations (r = .01, p = .95), body
vigilance (r = -.08, p = .35), or agoraphobic avoidance (r = .10, p = .28). AS Physical
Concerns was significantly correlated with the tendency to catastrophize about bodily
sensations (r = .67, p < .01), body vigilance (r = .62, p < .01), agoraphobic avoidance (r =
.38, p < .01), and a lifetime history of panic attacks (r = .23. p < .01). The associations
between the criterion variables were all significant except for the correlation between
body vigilance and lifetime history of panic attacks (r = .15, p = .09).
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Retention of participants during the follow-up period. 83.2% of the participants (n
= 104) returned for the Time 2 assessment and were thus included in the Time 2 analyses.
12% (n = 15) of the participants returning for the second assessment had experienced a
panic attack during the follow-up period; this is a sizeable percentage, underscoring the
clinically significant nature of this population, an issue that is returned to in the
Discussion Section.
Associations among the covariates, predictor variables and criterion variables at
Time 2. Lifetime history of panic attacks was significantly correlated with smoking rate (r
= .19, p < .05) and AS Physical Concerns (r = .23. p < .01). Time 1 anticipatory anxiety
was significantly associated with AS Physical Concerns (r = .29, p < .01), but not
smoking rate (r = .09, p = .34). Smoking rate was not significantly associated with the
presence of panic attacks during the follow-up period (r = .06, p = .56) or Time 2
anticipatory anxiety (r = .06, p = .56). Similarly, AS Physical Concerns was not
significantly associated with the presence of panic attacks during the follow-up period (r
= .10, p = .33) or Time 2 anticipatory anxiety (r = .14, p = .17).
Time 1 Regression Equations
Data for the Time 1 linear regression analyses are presented in Table 4. In terms
of the tendency to catastrophize about bodily sensations, the first step accounted for
50.9% of the variance. Negative affectivity was a significant predictor at step 1 of the
model (t = 10.91, β = .71, p <.01), but alcohol consumption was not (t = -.06, β = -.004, p
= .95). A significant main effect for AS Physical Concerns was found at step 2 of the
model (t = 3.49, β = .30, p <.01), but not smoking rate (t = -.61, β = -.04, p = .54).
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Contrary to prediction, the interaction between AS Physical Concerns and smoking rate
did not significantly predict the tendency to catastrophize about bodily sensations (t =
.70, β = .04, p = .48). 3
In terms of body vigilance, the first step accounted for 22.4% of the variance.
Negative affectivity was a significant predictor at step 1 of the model (t = 5.75, β = .47, p
<.01), but alcohol consumption was not a significant predictor (t = -.42, β = -.03, p = .68).
A significant main effect for AS Physical Concerns was found at step 2 of the model (t =
4.98, β = .51, p <.01), but no main effect was observed for smoking rate (t = -1.36, β = .11, p = .17). Contrary to prediction, the interaction between AS Physical Concerns and
smoking rate did not significantly predict body vigilance (t = .47, β = .04, p = .64).
In terms of agoraphobic avoidance, the first step accounted for 18.3% of the
variance. Negative affectivity was a significant predictor at step 1 of the model (t = 5.01,
β = .42, p <.01), but alcohol consumption was not a significant predictor (t = -1.04, β = .09, p = .30). There were no main effects for either AS Physical Concerns or smoking rate
at step 2 of the model (t = .96, β = .11, p = .34 and t = .90, β = .08, p = .37, respectively).
As hypothesized, the interaction between AS Physical Concerns and smoking rate did
significantly predict agoraphobic avoidance; the interaction accounted for 3.6% of unique
variance (t = 2.29, β = .19, p < .05).
Data for the Time 1 logistic regression is presented in Table 5. In terms of lifetime
history of panic attacks, negative affectivity (OR = 1.15, p < .01, 95% CI = 1.08-1.22),
but not alcohol consumption (OR = 1.03, p = .53, 95% CI = .94-1.13), was associated
with a unique change in the odds of having a lifetime history of panic attacks. Neither AS
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Physical Concerns (OR = .96, p = .33, 95% CI = .87-1.05) nor smoking rate (OR = 1.05,
p = .12, 95% CI = .99-1.11) were associated with a unique change in the odds of having a
lifetime history of panic attacks above and beyond the covariates. Finally, contrary to
prediction, the interaction between AS Physical Concerns and smoking rate was not
related to lifetime history of panic attacks (OR = 1.00, p = .71, 95% CI = .99-1.00).
Time 2 Regression Equations
Data for the Time 2 logistic regression analysis is presented in Table 6. In terms
of the presence of panic attacks during the three-month follow-up period, lifetime history
of panic attacks (OR = 8.42, p < .01, 95% CI = 2.56-27.68) was associated with a unique
change in the odds of experiencing a panic attack during the follow-up period. Neither
AS Physical Concerns (OR = .99, p = .78, 95% CI = .92-1.07) nor smoking rate (OR =
1.00, p = 1.00, 95% CI = .93-1.07) were associated with a unique change in the odds of
having panic attacks during the follow-up period above and beyond the covariate. Finally,
contrary to prediction, the interaction between AS Physical Concerns and smoking rate
was not related to increased likelihood of experiencing panic attacks during the follow-up
period (OR = 1.00, p = .86, 95% CI = .99-1.01).
Data for the Time 2 linear regression analysis is presented in Table 7. In terms of
anticipatory anxiety at Time 2, Time 1 anticipatory anxiety was not a significant predictor
at step 1 (t = .28, β = .03, p = .78). There were no main effects for either AS Physical
Concerns or smoking rate at step 2 of the model (t = 1.38, β = .14, p = .17 and t = .73, β =
.07, p = .47, respectively). As hypothesized, the interaction between AS Physical
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Concerns and smoking rate significantly predicted anticipatory anxiety at Time 2 (t =
2.32, β = .23, p < .05).
Graphical Representation of the Statistically Significant Interactions
Interactions were examined, in regard to hypothesized moderation, to determine
direction and significance. Statistically significant interactions were examined, in regard
to hypothesized moderation, both graphically (see Cohen & Cohen, 1983, for a review)
and analytically (Holmbeck, 2002), to determine direction and conceptual consistency
with the model. Based on recommendations of Cohen and Cohen (1983; pp. 323, 419),
the form of significant interactions were examined by inserting specific values for each
predictor variable into the regression equations associated with the described analysis.
Specifically, values for each predictor variable at one half of a standard deviation above
and below the mean for AS Physical Concerns and smoking rate, respectively, were
inserted into the regression equation and plotted.
Forms of the interactions supported the hypotheses (please see Figures 2 and 3).
Among individuals with higher AS Physical Concerns, smoking a greater number of
cigarettes was associated with higher levels of agoraphobic avoidance at Time 1, whereas
smoking rate had a relatively weaker association with agoraphobic avoidance across the
other variable combinations. A similar finding was evident for anticipatory anxiety at
Time 2. Again, higher levels of AS Physical Concerns and higher rates of daily smoking
were associated with the greatest elevations in anticipatory anxiety compared to other
variable combinations. These findings are in accord with the hypothesized effects.
Furthermore, based on recommendations of Holmbeck (2002), post-hoc probing analyses
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were conducted on the data to examine moderation. Results indicated that moderation
occurred for agoraphobic avoidance but not T2 anticipatory anxiety [t (116) = 4.03, p <
.01 and t (95) = 1.33, p = .19, respectively]. The association between smoking rate and
agoraphobic avoidance was moderated when AS Physical Concerns was high.
Discussion
There has been a growing level of clinical interest in better understanding the role
of smoking and other addictive behaviors in psychiatric conditions in recent years
(Zvolensky & Schmidt, 2004). This work has grown, at least partially, out of the
recognition that smoking often co-occurs with psychological problems such as anxiety
disorders and may be systematically related to the course of such psychopathology.
Despite the direct clinical and public health importance of addressing such matters, we
are only at the beginning stages of explicating the nature of smoking-anxiety
associations. The present study represents an effort to empirically evaluate a cognitive
vulnerability by smoking model related to panic processes using a cross-sectional and
prospective measurement protocol.
Findings from Time 1 Assessment
In regard to the cross-sectional analyses, as hypothesized, there was a significant
interaction between AS Physical Concerns and smoking rate in relation to agoraphobic
avoidance. These effects were above and beyond the variance accounted for by the
theoretically-relevant covariates and respective main effects. Inspection of the form of the
significant interaction was supportive of the theorized AS Physical Concerns by smoking
model of panic-vulnerability (see Figure 2). Specifically, at higher levels of AS Physical
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Concerns and higher smoking rates, there was a risk for increased agoraphobic
avoidance. It is noteworthy that the size of the interaction effect was meaningful at 3.6%
of unique variance (after controlling for the variance accounted for by the covariates and
main effects; Abelson, 1985). Moreover, such results replicate and extend past work on
AS and smoking in a Russian epidemiological sample (Zvolensky, Kotov et al., 2003).
Contrary to prediction, however, the interaction between AS Physical Concerns and
smoking rate did not significantly predict the tendency to catastrophize about bodily
sensations, body vigilance, or lifetime history of panic attacks. Thus, three out of the four
predictions were not supported from an a priori basis.
Overall, these Time 1 findings suggest that the interaction between the cognitive
vulnerability variable of AS and smoking rate is relatively specific to panic-relevant
avoidance behavior rather than applicable to all aspects of panic vulnerability (e.g., body
vigilance, catastrophic thinking, and panic attacks). Though cross-sectional in nature, this
pattern of findings, considered with those of Zvolensky, Kotov et al. (2003), may be used
to conceptually guide the refinement of etiological models of panic vulnerability that
involve smoking behavior. For example, rather than smoking rate and AS “combining” to
confer risk for all aspects of panic vulnerability, perhaps these two risk factors may
interplay only for certain risk processes like avoidance behavior. Then, once this type of
maladaptive behavior pattern “emerges,” other panic-relevant processes like anticipatory
anxiety, vigilance to somatic stimuli, panic attacks, catastrophic thinking, and so on, may
theoretically “follow.” These types of issues are broadly concerned with “timing” of
etiological processes.
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Theory and research on avoidance learning would be broadly consistent with the
above described type of affect regulation model (cf. self-medication model), whereby
escape and avoidance responding at Time 1 increased the risk for anxiety symptoms at a
future time period (Mineka, 1985). The basic premise in such models is that the organism
learns a contingency between an aversive environmental event and a response pattern that
serves to avoid contact with it (Zvolensky, Lejuez, & Eifert, 2000). Here, it is interesting
that these learning processes often can operate beyond conscious awareness. Thus, there
is an expected disconnect between declarative knowledge about various relevant stimuli
and the degree of emotional learning that has transpired, particularly during the early
phases of a conditioning process; a finding supported by a basic research (Bechara et al.,
1995). This type of work may partially explain why there was an observed disconnect
between self-rated avoidance (presumably, more automatized behavior tied to emotional
learning) and cognitive factors in the present investigation; that is, between the selfregulation factor of avoidance and the studied cognitive (presumably, declarative
knowledge) variables. Of course, given self-rating scales were used to assess both
avoidance and cognitive factors, these argument is more a theoretical prediction derived
from extant models to help explain the observed results rather than a complete
explanation for the observed results.
Building from such reasoning, as applied conceptually to the present research, it
may be that a daily smoker learns that certain situations may be evoking uncomfortable
bodily sensations or anxiety symptoms (theoretically produced, at least partially, by
smoking behavior over an extended period of time), and then starts to avoid such
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situations (“agoraphobic avoidance”). Here, it should be noted that the avoidance
assessment in the present study was geared toward “classic” general agoraphobic
situations (e.g., driving). According to the present perspective, however, avoidance could
be applied to more specific situations/behaviors as well (e.g., smoking to escape/avoid
escalating negative affect states). That is, there should be great variability in the
compensatory behaviors to reduce anxiety. As applied to smokers, tests involving
smoking motives may be a useful way to empirically evaluate such matters with more
specificity (e.g., AS by smoking rate predicting negative affect reduction smoking
motives). Additionally, it is important to bear in mind that the cross-sectional
methodology of the current study cannot differentiate such risk processes from
concomitants or consequences and thereby does not permit an empirical analysis of these
precise issues. However, the current results do set the exciting stage for future research to
follow from this study and empirically evaluate such a model; a perspective that we
return to in the discussion of the Time 2 analyses (see below).
It also is useful to briefly comment on the pattern of zero-order associations
among predictor and criterion variables at Time 1. Consistent with extant research
(Breslau & Klein, 1999), smoking rate and history of panic attacks were significantly
associated with one another. However, smoking rate was not significantly associated with
any of the panic-relevant process variables. Also, consistent with prior research, AS
Physical Concerns was significantly positively associated with all of the panic-related
variables. Furthermore, the association between AS Physical Concerns and smoking rate
was negligible, suggesting that these two variables are unique, or at least, largely
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independent risk factors. Of note, alcohol consumption was significantly negatively
correlated with smoking rate; these two variables are typically positively associated with
one another (e.g., Strine et al., 2005). This finding is likely due to unique characteristics
of this sample. Specifically, although this was a primarily young, college-student sample,
approximately 25% of the sample was from the community (older, community dwelling
individuals). The demographic characteristics of this subset of the sample were somewhat
different than those of the primarily college student sample. In particular, the community
participants reported drinking significantly less, smoking more, were older, and more
likely to have had drug or alcohol treatment (approximately 50% had a history of
substance abuse treatment). Thus, there may be unique patterns between community and
college-based samples in regard to smoking and alcohol use patterns.
Findings from Time 2 Assessment
In regard to the prospective analyses, there was a significant interaction between
AS Physical Concerns and smoking rate in relation to Time 2 anticipatory anxiety. These
effects were above and beyond the variance accounted for by the theoretically-relevant
covariate and respective main effects. Post hoc probing analysis of the form of the
significant interaction, however, was not supportive of the theorized AS Physical
Concerns by smoking model of panic-vulnerability. This finding may have been due to
insufficient power due to the smaller sample size at Time 2. Nonetheless, the size of the
interaction effect was clinically meaningful at 5% of unique variance (Abelson, 1985).
Drawing from research in other areas of psychology, prospective studies that follow
participants for shorter periods of time tend to generate smaller effects than those with
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longer follow-up periods (e.g., Rogosa, Brandt, & Zimowski, 1982). Thus, future studies
using longer follow-up assessments are necessary for sufficient numbers of participants
to show change in the outcome of interest or that multiple waves of data allow one to
model change more reliably. Also, contrary to prediction, the interaction between AS
Physical Concerns and smoking rate did not significantly predict the occurrence of panic
attacks during the three month follow-up period.
Considered with the Time 1 data, the Time 2 results shed further empirical light
on the nature of the AS Physical Concerns by smoking rate interaction in terms of panic
vulnerability. Specifically, not only does the interaction between AS Physical Concerns
and smoking rate concurrently predict agoraphobic avoidance (Time 1 analyses/findings),
but it also predicts future anticipatory anxiety in a relatively short window of time (Time
2 analyses/findings). These findings may portend the type of panic-relevant vulnerability
processes developing among this clinically-relevant daily smoking population.
Specifically, daily smokers smoking at higher rates with high AS Physical Concerns may
be more prone to engage in avoidance (Time 1 findings) and show increases in worry
about potentially threatening events in the future (Time 2 anticipatory anxiety findings).
One could anticipate that, given any number of adverse events (e.g., exposure to high
stress situations, unexpected panic attacks), that these individuals (i.e., heavier smokers
with high AS Physical Concerns) may be more prone than their lower smoking and lower
AS Physical Concerns counterparts to be more vulnerable to adverse emotional learning
between interoceptive cues and anxiety states. With more frequent learning experiences,
or even one salient (emotionally powerful) event, these factors may theoretically “work
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together” to potentiate risk for the future development of panic psychopathology. Clearly,
this type of account, although grounded in empirical observation and conceptual models
of panic-smoking comorbidity (Zvolensky & Bernstein, 2005), is currently highly
speculative. It therefore represents an exciting area for future research. The utilization of
time-sampling or ecological momentary memory assessment methodologies would be
one way to systematically move this line of inquiry further.
It also is useful to briefly comment on the pattern of zero-order associations
among predictor and criterion variables at Time 2. Smoking rate was not significantly
associated with panic related processes (anticipatory anxiety) or the occurrence of panic
attacks during the follow up period. In terms of panic attacks, this finding is consistent
with past research where the association between smoking and future panic attacks was
only significant among adolescents who smoked greater than 20 cigarettes per day
(Johnson et al., 2000). Thus, examining these same questions among heavy smokers may
be useful in isolating the parameters of the smoking rate-panic attack association. The
lack of association between anticipatory anxiety and smoking rate is consistent with Time
1 findings and those of Zvolensky, Kotov, et al. (2003) where there was no association
between smoking rate and anxious arousal symptoms (i.e., the pure, non-overlapping
symptoms of anxiety compared to depression). Furthermore, AS Physical Concerns also
was not associated with the Time 2 panic variables, likely due to the limited variability in
the Time 2 criterion variables. Indeed, case-level data inspection indicated that while
12% of the Time 2 sample experienced panic attacks during the follow-up period, only 5
individuals experienced any anticipatory anxiety and none to a “severe degree.”
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Clinical Implications
Results of the current study suggest the potential utility of addressing smoking
within the context of intervening among individuals at risk for developing panic attacks
and panic disorder. Specifically, smokers with panic risk factors like AS report using
smoking as a primary emotion regulation strategy (Zvolensky, Bonn-Miller et al., 2006),
creating an interconnection between smoking and panic. This interplay creates a situation
wherein intervention for one problem will ultimately be impaired, or perhaps altogether
unsuccessful, unless the other problem also is addressed simultaneously. Case reports are
consistent with this perspective (Zvolensky, Lejuez, Kahler, & Brown, 2003). As one
illustrative example, when smokers high in cognitive-based risk for panic (e.g., high AS)
make a smoking cessation attempt, they are (1) at high risk for being emotionally reactive
to internal cues including, but not limited to, nicotine withdrawal (Zvolensky, Feldner, et
al., 2005) and (2) “biased” to reduce such distress (avoidant coping), particularly when
alternative coping strategies are not available. Thus, AS and perhaps other panic-specific
factors would presumably “prime” motivational processing very early in the quit process.
In particular, an individual that is highly sensitive to negative affect and other internal
cues (e.g., high AS) would be apt to smoke, and thereby demonstrate early relapse, to
ameliorate aversive states elicited by smoking discontinuation. This type of example
theoretically illustrates the clinically-relevant linkages between panic factors and
smoking behavior in terms of self-regulation processes and cessation. Similar examples
could be made in regard to other directional effects; that is, from smoking to panic
vulnerability, an issue fully addressed in the Introduction Section of the present study and
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thus not repeated here. In total, if accurate, this forward feeding type of cycle creates the
need for an integrated intervention that reduces panic problems while considering the role
of smoking in the larger “psychological context” of therapeutic care. One could imagine
it would be applicable to not only people at risk for developing panic psychopathology,
but also smokers with full-blown panic problems.
Study Limitations and Future Directions
Although the present study adds to the extant literature on smoking and panicrelevant variables in a unique manner, there are a number of interpretive caveats that
deserve further comment. First, although we used community-based advertisements in
the recruitment of participants for the present investigation, it is noteworthy that the
sample was comprised of relatively young adult daily smokers. The sample may have
been younger, on average, than would be expected from typical community-based
recruitment due to the fact that advertisements for the study were largely posted in areas
of the community frequently visited by young adults (e.g., shopping centers, restaurants,
bars) and therefore may have attracted younger adults to a greater extent than older adult
smokers. Second, the sample was comprised of regular (daily), but not heavy, smokers.
As previous research indicates that the panic-smoking association often is most apparent
among heavy smokers, it may prove fruitful for future research to examine panicvulnerability associations in light, moderate, and heavy smokers. Along these same lines,
it may be useful to compare panic-vulnerability associations with smoking rate vs.
nicotine dependence. A comparison of smoking rate and dependence in the prediction of
panic problems would serve to increase specificity of the current biopsychosocial model
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of panic disorder etiology by specifying which factor(s) play more formative roles in
promoting risk. Third, although the sample was representative of the ethnic composition
of the state of Vermont, it was comprised of predominately Caucasian young adults. To
improve generalizability of the observed effects, future research could sample from
locations with more diverse demographic characteristics. Fourth, a three-month follow up
period is a fairly short period of time. Although we opted to design the present
investigation for 3-month follow-up to establish precedent for examining these matters
and assess retention rates among this at-risk population, large changes in
symptomatology during this specific window of time were not evident. Future studies
employing longer follow up periods would better document symptom progression.
Fifth, and somewhat related to the prospective design comment, is that we utilized
hierarchical linear regression tools for indexing the observed effects. Although a
reasonable analytic option, these techniques are not as powerful as random regression
growth curve models and hazard models for modeling change. We used linear regression
in the present study due to the size of the recruited sample and rather limited focus on one
interactive process. Building from the present study, it would be advisable to construct
more powerful tests and use even more sensitive analytic tools for indexing change.
Sixth, in terms of effect size for the observed significant interactions, meaningful effect
sizes are being found (e.g., 3% to 5% of variance). However, the clinical significance of
effects of this size depends on the context in which they are examined. Here, while such
effect sizes may be a “good start”, they simultaneously underscore that the vast majority
of variance is not explained. Clearly, continuing to refine and evaluate theoretically-
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driven models of risk are critical. Seventh, self-report measures were utilized as the
primary assessment methodology for many of the key constructs. The utilization of selfreport methods does not fully protect against reporting errors and may be influenced by
shared method variance. Thus, future studies could build on the present work by utilizing
laboratory based assessments to provide information about smoking behavior in “real
time.” For example, evaluating the predictive power of AS by smoking rate in the
prediction of emotional responsivity to biological challenge would help document
response patterns across systems. Again, such data could then be used to refine
theoretical models. Finally, in the broadest “causal model” of panic vulnerability,
moderators influence the relation between a given risk factor and panic outcomes. The
present study, grounded in such a heuristic model to guide theoretical predictions,
addressed one such moderator (AS). However, future work needs to build on the present
study and address other moderating factors with specified theoretical relevance to the
overarching panic vulnerability model. Additionally, research should begin to address
mediators, which theoretically explain the relation between a given risk factor and panic
psychopathology. This type of work will, as a “system”, begin to lay the groundwork for
even more advanced tests that attempt to explicate the direction of such processes and
incorporate multi-variable modeling of effects.
Conclusions
Together, the present findings suggest daily smokers who have higher smoking
rates and higher levels of AS Physical Concerns report greater agoraphobic avoidance
and increases in anticipatory anxiety over a short period of time. The primary implication
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of the present findings is that there may be segments of the cigarette smoking population
who are at relatively greater risk for panic symptoms by virtue of individual differences
in AS. The identification of such moderating effects is clinically important, as it helps to
refine our understanding of complex associations between drug behavior and panic
vulnerability.
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Footnotes
1

Regular cigarette smoking does not necessarily indicate that the individual is

nicotine dependent. Nicotine dependence implies that the individual meets DSM-IV
criteria for substance dependence which include symptoms of tolerance, withdrawal,
inability to cut down or stop use, stopping social, occupational, or recreational activities
because of substance use, and continued use despite knowledge of having a persistent
physical or psychological problem because of substance use (APA, 2000). Most studies
on smoking and PD do not indicate whether or not subjects are nicotine dependent per se.
In this same context, it is important to note that the term “addiction” will be used instead
of drug dependence. This is done for several key reasons. Specifically, “dependence”
does not offer any explanatory meaning over and above “addiction.” Both reflect patterns
of drug use that impart some cost on the individual; are difficult to stop; typically recur
after discontinuation; and are characterized, in part, by tolerance and withdrawal. Also,
by employing the term dependence, confusion at a conceptual level can be created
because of the more specific term of physical dependence. Physical dependence reflects a
state in which reduced drug levels elicit withdrawal symptoms.
2

Gender was not included as a covariate in the current study as the sample size did

not allow for it. Furthermore, there have been no gender effects found in past work or
theoretical models; thus, there was little reason to examine this factor here. However,
future research that involves larger sample sizes should address this factor and
incorporate it into contemporary models.
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3

Due to the overlap between the tendency to misinterpret bodily sensations

[measured by the Brief Body Sensations Interpretation Questionnaire (BBSIQ)] and the
tendency to catastrophize about bodily sensations (ACQ), only the results from the ACQ
are presented here and not for the BBSIQ as originally proposed. The validity of the
BBSIQ in the current study was questionable as participants consistently had difficulty
understanding the instructions for completing the BBSIQ despite explanations from the
research team. Regression analyses were run using the BBSIQ as a criterion variable and
the interaction between AS Physical Concerns and smoking rate did not significantly
predict the tendency to misinterpret bodily sensations (t = -.89, β = -.07, p = .37).
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Table 1: Key Terms in Risk Factor Research (from Kraemer et al., 1997)

Correlate:

Two characteristics shown to be associated without any
implication of a temporal or directional relation.

Risk Factor:

A characteristic that has been shown to precede the
outcome and to be associated with an increase in the
likelihood of that outcome over base rates in the general
population. This requires unequivocally demonstrating the
temporal sequence that entails evidence that the outcome
was not evident prior to or at the time of the antecedent
event.

Marker:

A risk factor that is not causally involved in the outcome.
Fixed marker is used to refer to risk factors that are not
considered malleable; variable marker is used for those risk
factors that change or can be changed.

Causal Risk Factor: A risk factor that, when altered, has impact on the
likelihood of the outcome. A causal role of the risk factor in
the outcome is bolstered by collateral evidence regarding
the mechanisms involved in the risk-outcome relation.
Demonstration that an event is a causal risk factor is not
tantamount to saying that antecedent event is the causal risk
factor. Inherent in the risk factor approach is the possibility
that there may be multiple causal risk factors and multiple
paths toward an outcome of interest.
__________________________________________________________________

78

Table 2: Overview of Procedure

Screening
• Telephone Screening
• Appointment for assessment set
Assessment
• Informed consent
• Structured Interviews and medical screening
o SCID-NP
o Panic Disorder Severity Scale (PDSS)
• CO analysis
• Self-report questionnaires
o Anxiety Sensitivity Index (ASI)
o Agoraphobic Cognitions Questionnaire (ACQ)
o Body Vigilance Scale (BVS)
o Positive and Negative Affect Scale (PANAS)
o Fagerstrom Test for Nicotine Dependence (FTND)
o Smoking History Questionnaire (SHQ)
o Alcohol Use Disorders Identification Test (AUDIT)
• Compensation
Follow-Up
• Interview
o SCID-NP (panic attack module)
o Panic Disorder Severity Scale (PDSS)
• De-briefing
• Compensation
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Table 3: Descriptive Data and Intercorrelations among Predictor and Criterion Variables
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1

2

3

4

5

6

7

8

9

10

11

M

SD

1. PANAS-NA

-

.03

.14

.67**

.68**

.46**

.36**

.39**

.25**

.27**

.17

21.3

8.46

2. Alcohol

-

-

-.30**

.02

.00

.00

-.07

.01

-.17

-.05

-.11

6.68

5.36

3. Cig/Day

-

-

-

-.04

.01

-.08

.10

.19*

.09

.06

.06

17.6

8.43

4. ASI-PC

-

-

-

-

.67**

.62**

.38**

.23**

.29**

.10

.14

11.6

8.28

5. ACQ

-

-

-

-

-

.45**

.46**

.35**

.36**

.25**

.07

1.53

0.49

6. BVS

-

-

-

-

-

-

.26**

.15

.20*

.04

.08

16.0

8.28

7. T1 Avoidance

-

-

-

-

-

-

-

.41**

.81**

.08

-.06

0.21

0.73

8. T1 Panic Attacks

-

-

-

-

-

-

-

-

.36**

.36

.22*

-

-

9. T1 AA

-

-

-

-

-

-

-

-

-

.03

.03

0.12

0.52

10. T2 Panic Attacks

-

-

-

-

-

-

-

-

-

-

.42**

-

-

11. T2 AA

-

-

-

-

-

-

-

-

-

-

-

0.06

0.27

Note. A single asterisk indicates correlation is significant at .05 level; A double asterisk indicates correlation is significant at .01 level; PANAS:
Positive and Negative Affect Scale- Negative Affectivity subscale (Watson, Clark, & Tellegen, 1988); Alcohol: Weekly Alcohol Consumption;
Cig/Day: Daily Cigarettes; ASI-PC: Anxiety Sensitivity Index- Physical Concerns subscale (Reiss et al., 1986); ACQ: Agoraphobic Cognitions
Questionnaire (Chambless et al., 1984); BVS: Body Vigilance Scale (Schmidt, Lerew, & Trakowski, 1997); T1 Avoidance: Agoraphobic
Avoidance at Time 1 assessed via PDSS (Shear et al., 1997); T1 Panic Attacks: History of panic attacks (yes/no) assessed via SCID-NP (First et
al., 1995); T1 AA: Anticipatory Anxiety at Time 1 assessed via PDSS (Shear et al., 1997); T2 Panic Attacks: Panic attacks during 3-month
follow up period (yes/no) assessed via SCID-NP (First et al., 1995); T2 AA: Anticipatory Anxiety at Time 2 assessed via PDSS (Shear et al.,
1997).

Table 4: Contribution of the Interaction between AS Physical Concerns and Smoking
Frequency in Predicting Time 1 Panic-Relevant Variables
ΔR2

t (each predictor)

β

sr2

p

Criterion Variable: Catastrophizing Bodily Sensations
Step 1
.51
Negative Affectivity
10.91
.71
.50
Alcohol consumption
-.06
.00
.00

<.01
<.01
ns

Step 2
AS-PC
Smoking Rate

.05
.10
.00

<.01
<.01
ns

Step 3
AS-PC x Smoking Rate

.00
.04

.00

ns
ns

.47
-.03

.22
.00

<.01
<.01
ns

4.98
-1.36

.51
-.11

.18
.02

<.01
<.01
ns

.47

.04

.00

ns
ns

.18
.01

<.01
<.01
ns

.01
.01

ns
ns
ns

Step 1
Negative Affectivity
Alcohol consumption

3.49
-.61
.70
Criterion Variable: Body Vigilance
.22
5.75
-.42

Step 2
AS-PC
Smoking Rate

.16

Step 3
AS-PC x Smoking Rate

.00

.30
-.04

Criterion Variable: Agoraphobic Avoidance
Step 1
.18
Negative Affectivity
5.01
.42
Alcohol consumption
-1.04
-.09
Step 2
AS-PC
Smoking Rate

.01
.96
.90

.11
.08

Step 3
.04
<.05
AS-PC x Smoking Rate
2.29
.19
.04
<.05
________________________________________________________________________
Note. n = 125; AS-PC = AS Physical Concerns; β = standardized beta weight; sr2 =
squared partial correlation
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Table 5: Contribution of the Interaction between AS Physical Concerns and Smoking
Frequency in Predicting Lifetime History of Panic Attacks
Panic Attacks
Step 1
Negative Affectivity
1.14 (1.08-1.22)*
Alcohol Consumption
1.03 (.94-1.13)
Step 2
AS-PC
.96 (.87-1.05)
Smoking Rate
1.05 (.99-1.11)
Step 3
AS-PC x Smoking Rate
1.00 (.99-1.00)
Note. Significant ORs are in bold type.*p < .01
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Table 6: Contribution of the Interaction between AS Physical Concerns and Smoking
Frequency in Predicting Time 2 Panic Attacks
Time 2 Panic Attacks
Step 1
Time 1 Panic Attacks
8.42 (2.56-27.68)*
Step 2
AS-PC
.99 (.92-1.07)
Smoking Rate
1.00 (.93-1.07)
Step 3
AS-PC x Smoking Rate
1.00 (.99-1.01)
Note. Significant ORs are in bold type.*p < .01
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Table 7: Contribution of the Interaction between AS Physical Concerns and Smoking
Frequency in Predicting Time 2 Anticipatory Anxiety
ΔR2

t (each predictor)

β

Criterion Variable: Time 2 Anticipatory Anxiety
Step 1
.00
T1 Anticipatory Anxiety
.28
.03
Step 2
AS-PC
Smoking Rate

sr2

p

.00

ns
ns

.02
.00

ns
ns
ns

.02
1.38
.73

.14
.07

Step 3
.05
<.05
AS-PC x Smoking Rate
2.32
.23
.05
<.05
________________________________________________________________________
Note. n = 104; AS-PC = AS Physical Concerns; β = standardized beta weight; sr2 =
squared partial correlation
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Figure 1: Conceptual Model depicting Anxiety Sensitivity Moderating the Effects of
Smoking on Panic Vulnerability

Smoking
Level

Panic

AS
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Figure 2: Time 1 Agoraphobic Avoidance, as indexed by the Panic Disorder Severity
Scale (Shear et al., 1997), as a function of AS Physical Concerns and number of
cigarettes smoked per day among participants one-half of a standard deviation above
and/or below the mean for each predictor.
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Figure 3: Time 2 Anticipatory Anxiety, as indexed by the Panic Disorder Severity Scale
(Shear et al., 1997), as a function of AS Physical Concerns and number of cigarettes
smoked per day among participants one-half of a standard deviation above and/or below
the mean for each predictor.
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